Physician profile
Ryan Peter Barmore
NPI 1962841593
$2,508.91
in general payments reported to CMS, 2019-2025
12 companies · $307 in 2025
The $307 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $93.73 · 2021: $113 · 2022: $1,181 · 2023: $129 · 2024: $316 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,102.46 | 2022-2023 | |
| Medtronic, INC. | $450.79 | 2022-2025 | Percept Pc Brainsense, Sensight |
| Medtronic USA, INC. | $303.03 | 2019 | |
| Abbvie INC. | $216.30 | 2019-2025 | Botox |
| Abbott Laboratories | $118.88 | 2019-2024 | Infinity |
| Alexion Pharmaceuticals, INC. | $85.13 | 2024 | Ultomiris |
| Novartis Pharmaceuticals Corporation | $75.62 | 2025 | |
| Allergan, INC. | $50.47 | 2021 | |
| Ucb, INC. | $36.97 | 2020 | |
| Emd Serono, INC. | $31.32 | 2019 | |
| Biogen, INC. | $20.65 | 2020 | |
| Lilly USA, LLC | $17.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Barmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.